IRTC

Tempus AI demonstrated improving operating leverage in Q2 2026 with 22% revenue growth to $382.5M and adjusted EBITDA reaching $8M (a $13.6M improvement). The company completed a $460M convertible notes offering expected to reduce annual interest expenses by over $30M. Tempus raised its 2026 revenue guidance to $1.595-$1.605B while maintaining adjusted EBITDA guidance of $65M, supporting its goal of achieving positive free cash flow by year-end 2026.

Tempus AI (TEM) shares gained 17.9% over the past month, outperforming peers like Claritev and iRhythm, driven by strong demand for healthcare AI. The company reported 28% revenue growth in its Data and Applications segment to $93.2M in Q2, with Insights revenues up 36%.

However, TEM trades at a premium valuation of 6.59X sales versus the industry average of 4.70X, and its growth depends heavily on regulatory approvals and reimbursement decisions. Analysts recommend current holders maintain positions while prospective investors wait for a more favorable entry point.

Edelson Lechtzin LLP is investigating a data breach at the Shipping Association of New York and New Jersey after unauthorized access on May 27, 2026 exposed personal information of benefit plan participants. The Qilin ransomware group claimed responsibility for the theft.

Affected data may include names, Social Security numbers, driver's license numbers, and medical information. The law firm is offering free case evaluations for potential class action claims.

iRhythm Holdings, a San Francisco-based heart-monitoring company, suffered a data breach in June 2026 affecting approximately 8 million patients. Unauthorized access to third-party business applications exposed sensitive patient information including names, contact details, insurance numbers, and device serial numbers.

The company disclosed the incident to the SEC and began notifying affected individuals in October 2026. A national class action law firm is investigating potential claims for compensation.